Analyst Articles – Company Sum

Investment Analysts’ Recent Ratings Updates for CF Industries Holdings (CF)

Several analysts have recently updated their ratings and price targets for CF Industries Holdings (NYSE: CF): 1/16/2017 – CF Industries Holdings was downgraded by analysts at Zacks Investment Research from a “strong-buy” rating to a “hold” rating. According to Zacks, “CF Industries has outperformed the Zacks categorized Fertilizers industry in the past three months, aided […]

Investment Analysts’ Weekly Ratings Changes for VCA (WOOF)

Several brokerages have updated their recommendations and price targets on shares of VCA (NASDAQ: WOOF) in the last few weeks: 1/11/2017 – VCA was downgraded by analysts at Credit Suisse Group from an “outperform” rating to a “neutral” rating. They now have a $93.00 price target on the stock, up previously from $76.00. 1/10/2017 – […]

UnitedHealth Group (UNH) – Research Analysts’ Recent Ratings Changes

UnitedHealth Group (NYSE: UNH) recently received a number of ratings updates from brokerages and research firms: 1/10/2017 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Jefferies Group. They now have a $2.30 price target on the stock. 1/9/2017 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Barclays PLC. They […]

Baidu (BIDU) – Investment Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Baidu (NASDAQ: BIDU): 1/17/2017 – Baidu is now covered by analysts at Morgan Stanley. They set an “equal weight” rating and a $185.00 price target on the stock. 1/17/2017 – Baidu had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now […]

Investment Analysts’ Recent Ratings Updates for American Express Company (AXP)

Several analysts have recently updated their ratings and price targets for American Express Company (NYSE: AXP): 1/17/2017 – American Express Company was upgraded by analysts at J P Morgan Chase & Co from a “neutral” rating to an “overweight” rating. They now have a $90.00 price target on the stock, up previously from $76.00. 1/12/2017 […]

Research Analysts’ Weekly Ratings Changes for Devon Energy Corporation (DVN)

A number of research firms have changed their ratings and price targets for Devon Energy Corporation (NYSE: DVN): 1/17/2017 – Devon Energy Corporation was downgraded by analysts at Jefferies Group from a “buy” rating to a “hold” rating. They now have a $48.00 price target on the stock. 1/16/2017 – Devon Energy Corporation was downgraded […]

Weekly Research Analysts’ Ratings Changes for Lumentum Holdings (LITE)

Several brokerages have updated their recommendations and price targets on shares of Lumentum Holdings (NASDAQ: LITE) in the last few weeks: 1/6/2017 – Lumentum Holdings had its “strong-buy” rating reaffirmed by analysts at Needham & Company LLC. 1/5/2017 – Lumentum Holdings had its “buy” rating reaffirmed by analysts at B. Riley. 12/29/2016 – Lumentum Holdings […]

Weekly Investment Analysts’ Ratings Changes for Diageo plc (DGE)

A number of research firms have changed their ratings and price targets for Diageo plc (LON: DGE): 1/17/2017 – Diageo plc had its price target raised by analysts at Credit Suisse Group from GBX 2,370 ($28.59) to GBX 2,430 ($29.32). They now have an “outperform” rating on the stock. 1/17/2017 – Diageo plc had its […]

Weekly Research Analysts’ Ratings Changes for International Business Machines Corporation (IBM)

Several brokerages have updated their recommendations and price targets on shares of International Business Machines Corporation (NYSE: IBM) in the last few weeks: 1/17/2017 – International Business Machines Corporation had its “buy” rating reaffirmed by analysts at Drexel Hamilton. 1/13/2017 – International Business Machines Corporation had its “overweight” rating reaffirmed by analysts at Morgan Stanley. […]

Weekly Research Analysts’ Ratings Changes for Brooks Automation (BRKS)

Several brokerages have updated their recommendations and price targets on shares of Brooks Automation (NASDAQ: BRKS) in the last few weeks: 1/16/2017 – Brooks Automation had its “buy” rating reaffirmed by analysts at B. Riley. They now have a $21.00 price target on the stock. 1/11/2017 – Brooks Automation had its “buy” rating reaffirmed by […]

Investment Analysts’ Weekly Ratings Changes for Senior Housing Properties Trust (SNH)

A number of research firms have changed their ratings and price targets for Senior Housing Properties Trust (NYSE: SNH): 1/5/2017 – Senior Housing Properties Trust was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Senior Housing Properties Trust is a Maryland real estate investment trust […]

Weekly Investment Analysts’ Ratings Changes for BCE (BCE)

BCE (NYSE: BCE) recently received a number of ratings updates from brokerages and research firms: 1/10/2017 – BCE was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “BCE continues to face multiple headwinds. Regulatory measures, loss in network access services lines, price competition, labor union […]

Analysts’ Recent Ratings Updates for Jupiter Fund Management PLC (JUP)

A number of research firms have changed their ratings and price targets for Jupiter Fund Management PLC (LON: JUP): 1/16/2017 – Jupiter Fund Management PLC had its “underperform” rating reaffirmed by analysts at BNP Paribas. They now have a GBX 415 ($5.01) price target on the stock. 1/12/2017 – Jupiter Fund Management PLC had its […]

Weekly Analysts’ Ratings Updates for Albemarle Corporation (ALB)

Albemarle Corporation (NYSE: ALB) recently received a number of ratings updates from brokerages and research firms: 1/17/2017 – Albemarle Corporation was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $118.00 price target on the stock, up previously from $81.00. 1/12/2017 – Albemarle Corporation had […]

CVS Health Corporation (CVS) – Investment Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for CVS Health Corporation (NYSE: CVS): 1/9/2017 – CVS Health Corporation was upgraded by analysts at Vetr from a “hold” rating to a “buy” rating. They now have a $86.87 price target on the stock. 1/3/2017 – CVS Health Corporation was downgraded by analysts at […]

St. James's Place plc (STJ) – Investment Analysts’ Recent Ratings Changes

St. James's Place plc (LON: STJ) has recently received a number of price target changes and ratings updates: 1/13/2017 – St. James's Place plc had its price target raised by analysts at Goldman Sachs Group, Inc. (The) from GBX 1,095 ($13.21) to GBX 1,145 ($13.81). They now have a “buy” rating on the stock. 1/10/2017 […]

Recent Analysts’ Ratings Updates for Nabors Industries (NBR)

A number of research firms have changed their ratings and price targets for Nabors Industries (NYSE: NBR): 1/12/2017 – Nabors Industries was given a new $15.00 price target on by analysts at BMO Capital Markets. They now have a “hold” rating on the stock. 1/4/2017 – Nabors Industries was upgraded by analysts at Credit Suisse […]

Recent Research Analysts’ Ratings Changes for HealthSouth Corporation (HLS)

HealthSouth Corporation (NYSE: HLS) recently received a number of ratings updates from brokerages and research firms: 1/10/2017 – HealthSouth Corporation was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “HEALTHSOUTH Corp. is the one of the nation’s largest providers of outpatient surgery and rehabilitative healthcare […]

Weekly Investment Analysts’ Ratings Changes for Akamai Technologies (AKAM)

A number of research firms have changed their ratings and price targets for Akamai Technologies (NASDAQ: AKAM): 1/12/2017 – Akamai Technologies was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “buy” rating. They now have a $79.00 price target on the stock. According to Zacks, “Akamai is likely to benefit […]

Recent Analysts’ Ratings Updates for Monsanto Company (MON)

A number of research firms have changed their ratings and price targets for Monsanto Company (NYSE: MON): 1/10/2017 – Monsanto Company was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $122.00 price target on the stock. According to Zacks, “Over the last one month, […]

Acorda Therapeutics (ACOR) – Investment Analysts’ Weekly Ratings Changes

Acorda Therapeutics (NASDAQ: ACOR) recently received a number of ratings updates from brokerages and research firms: 1/9/2017 – Acorda Therapeutics had its “hold” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $21.00 price target on the stock. 1/9/2017 – Acorda Therapeutics had its “buy” rating reaffirmed by analysts at Cowen and Company. […]

Cognizant Technology Solutions Corporation (CTSH) – Research Analysts’ Weekly Ratings Updates

A number of research firms have changed their ratings and price targets for Cognizant Technology Solutions Corporation (NASDAQ: CTSH): 1/10/2017 – Cognizant Technology Solutions Corporation is now covered by analysts at Loop Capital. They set a “hold” rating and a $60.00 price target on the stock. 1/9/2017 – Cognizant Technology Solutions Corporation was upgraded by […]

Weekly Analysts’ Ratings Changes for Spirit Aerosystems Holdings (SPR)

A number of firms have modified their ratings and price targets on shares of Spirit Aerosystems Holdings (NYSE: SPR) recently: 1/17/2017 – Spirit Aerosystems Holdings was downgraded by analysts at Bank of America Corporation from a “neutral” rating to an “underperform” rating. They now have a $55.00 price target on the stock, up previously from […]

AstraZeneca plc (AZN) – Investment Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of AstraZeneca plc (LON: AZN) in the last few weeks: 1/17/2017 – AstraZeneca plc had its “hold” rating reaffirmed by analysts at Liberum Capital. They now have a GBX 5,200 ($62.73) price target on the stock. 1/15/2017 – AstraZeneca plc had its “neutral” rating […]

Analysts’ Recent Ratings Updates for adidas AG (ADS)

adidas AG (FRA: ADS) recently received a number of ratings updates from brokerages and research firms: 1/12/2017 – adidas AG was given a new €150.00 ($159.57) price target on by analysts at Commerzbank AG. They now have a “neutral” rating on the stock. 12/30/2016 – adidas AG was given a new €180.00 ($191.49) price target […]

Investment Analysts’ Recent Ratings Changes for Seven Generations Energy (VII)

Seven Generations Energy (TSE: VII) has recently received a number of price target changes and ratings updates: 1/16/2017 – Seven Generations Energy had its “outperform” rating reaffirmed by analysts at Scotiabank. They now have a C$36.00 price target on the stock. 1/10/2017 – Seven Generations Energy had its “action list buy” rating reaffirmed by analysts […]

Weekly Research Analysts’ Ratings Changes for Yamana Gold (YRI)

Several brokerages have updated their recommendations and price targets on shares of Yamana Gold (TSE: YRI) in the last few weeks: 1/13/2017 – Yamana Gold had its “sector perform” rating reaffirmed by analysts at Scotiabank. They now have a C$4.00 price target on the stock. 1/10/2017 – Yamana Gold had its price target lowered by […]

Weekly Research Analysts’ Ratings Changes for Deckers Outdoor Corporation (DECK)

Several brokerages have updated their recommendations and price targets on shares of Deckers Outdoor Corporation (NYSE: DECK) in the last few weeks: 1/13/2017 – Deckers Outdoor Corporation had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $70.00 price target on the stock. 1/10/2017 – Deckers Outdoor Corporation was downgraded by […]

Analysts’ Weekly Ratings Changes for Zoopla Property Group PLC (ZPLA)

A number of firms have modified their ratings and price targets on shares of Zoopla Property Group PLC (LON: ZPLA) recently: 1/16/2017 – Zoopla Property Group PLC had its ” neutral” rating reaffirmed by analysts at BNP Paribas. They now have a GBX 320 ($3.86) price target on the stock. 1/16/2017 – Zoopla Property Group PLC […]

Research Analysts’ Recent Ratings Updates for K2M Group Holdings (KTWO)

Several analysts have recently updated their ratings and price targets for K2M Group Holdings (NASDAQ: KTWO): 1/11/2017 – K2M Group Holdings was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “K2M Group Holdings, Inc. is a global medical device company. The Company is focused on […]

Recent Investment Analysts’ Ratings Changes for HSBC Holdings plc (HSBA)

Several brokerages have updated their recommendations and price targets on shares of HSBC Holdings plc (LON: HSBA) in the last few weeks: 1/16/2017 – HSBC Holdings plc was given a new GBX 775 ($9.42) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock. 1/13/2017 […]

Recent Analysts’ Ratings Changes for Shire PLC (SHP)

Several analysts have recently updated their ratings and price targets for Shire PLC (LON: SHP): 1/15/2017 – Shire PLC had its “outperform” rating reaffirmed by analysts at BNP Paribas. They now have a GBX 5,900 ($71.75) price target on the stock. 1/9/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Bryan, Garnier […]

Egalet Corporation (EGLT) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Egalet Corporation (NASDAQ: EGLT) recently: 1/13/2017 – Egalet Corporation was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in the […]

Global Payments (GPN) – Research Analysts’ Recent Ratings Updates

Global Payments (NYSE: GPN) has recently received a number of price target changes and ratings updates: 1/11/2017 – Global Payments had its “outperform” rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $88.00 price target on the stock, up previously from $85.00. 1/11/2017 – Global Payments was upgraded by analysts at Zacks […]

Crew Energy (CR) – Investment Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of Crew Energy (TSE: CR) recently: 1/9/2017 – Crew Energy was downgraded by analysts at Royal Bank Of Canada from an “outperform” rating to a “sector perform” rating. They now have a C$9.00 price target on the stock. 1/6/2017 – Crew Energy […]

Research Analysts’ Recent Ratings Changes for Imperial Tobacco Group PLC (IMB)

Several brokerages have updated their recommendations and price targets on shares of Imperial Tobacco Group PLC (LON: IMB) in the last few weeks: 1/12/2017 – Imperial Tobacco Group PLC had its “buy” rating reaffirmed by analysts at Whitman Howard. They now have a GBX 5,100 ($62.02) price target on the stock. 1/12/2017 – Imperial Tobacco […]

Investment Analysts’ Recent Ratings Updates for Zoetis (ZTS)

Several brokerages have updated their recommendations and price targets on shares of Zoetis (NYSE: ZTS) in the last few weeks: 1/7/2017 – Zoetis was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Zoetis, one of the leading global animal health companies, is focused on both […]

Research Analysts’ Weekly Ratings Updates for Allergan plc (AGN)

Several analysts have recently updated their ratings and price targets for Allergan plc (NYSE: AGN): 1/9/2017 – Allergan plc was upgraded by analysts at Vetr from a “sell” rating to a “hold” rating. They now have a $224.07 price target on the stock. 1/6/2017 – Allergan plc had its “buy” rating reaffirmed by analysts at […]

Investment Analysts’ Recent Ratings Updates for Regeneron Pharmaceuticals (REGN)

A number of firms have modified their ratings and price targets on shares of Regeneron Pharmaceuticals (NASDAQ: REGN) recently: 1/10/2017 – Regeneron Pharmaceuticals had its “market perform” rating reaffirmed by analysts at Wells Fargo & Company. 1/10/2017 – Regeneron Pharmaceuticals had its “outperform” rating reaffirmed by analysts at Leerink Swann. 1/9/2017 – Regeneron Pharmaceuticals was […]

Research Analysts’ Recent Ratings Changes for Heron Therapeutics (HRTX)

A number of research firms have changed their ratings and price targets for Heron Therapeutics (NASDAQ: HRTX): 1/6/2017 – Heron Therapeutics had its “buy” rating reaffirmed by analysts at Cowen and Company. They now have a $40.00 price target on the stock. They wrote, “Yesterday Heron released positive Ph 2 abdominoplasty data for HTX-011.”” 1/6/2017 […]